Leigh Drogen and Joe McCann, founder of Slingshot Insights. discuss the current state of the health care industry, and look at quarterly expectations for upcoming biotech and pharma companies. (Audio Length: 00:30:20)
Welcome. We are pleased to be joined by Joe McCann, founder of Slingshot Insights. In this episode, Leigh and Joe discuss the current state of the health care industry, and look at quarterly expectations for upcoming biotech and pharma companies such as Gilead Sciences (GILD), Merck (MRK), Biogen Idec (BIIB), Celgene (CELG) and Pfizer (PFE).
Audio Length: 00:30:20
There can be no assurance that the information we considered is accurate or complete, nor can there be any assurance that our assumptions are correct.
Comments
Log in or sign up to join the conversation.